DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Topotecan
Topotecan
SAAVTC Protocol
Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride
Tandem High-Dose Chemotherapy with Topotecan–Thiotepa–Carboplatin
Cyclophosphamide and Topotecan As First-Line Salvage Therapy in Patients with Relapsed Ewing Sarcoma at a Single Institution
The Role of ABCG2 in Modulating Responses to Anti-Cancer Photodynamic Therapy
BC Cancer Benefit Drug List September 2021
Arsenic Trioxide As a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study
Complications of Intrathecal Chemotherapy in Adults
Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: a Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization
Mobilization Topotecan–Filgrastim Combination Is an Effective Regimen
A Phase I Clinical Trial of the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib And
Oral Topotecan Given Once Or Twice Daily for Ten Days: a Phase I Pharmacology Study in Adult Patients with Solid Tumors
Chemotherapy and Polyneuropathies Grisold W, Oberndorfer S Windebank AJ European Association of Neurooncology Magazine 2012; 2 (1) 25-36
Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors
CISPLATIN-TOPOTECAN (Intravenous)
Photodiagnosis and Photodynamic Therapy 21 (2018) 121–127
Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions
Topotecan: What Dose, What Schedule, What Route?1
Top View
The Microtubule-Stabilizing Agents Epothilones a and B and Their Desoxy-Derivatives Induce Mitotic Arrest and Apoptosis in Human Prostate Cancer Cells
Centre for Reviews and Dissemination Topotecan, Pegylated Liposomal
Pharmacokinetically Guided Phase I Trial of Topotecan and Etoposide Phosphate in Recurrent Ovarian Cancer
Phase II Study of Topotecan and Etoposide As Second-Line Treatment in Chemotherapy-Refractory Small-Cell Lung Cancer
Systemic MEK Inhibition Enhances the Efficacy of 5-Aminolevulinic Acid
Topotecan and Doxorubicin Combination to Treat Recurrent
29, 37 Acantholytic Carcinoma, 141 Ac1arubicin, 214 Acquired
DRUG NAME: Topotecan
2019 Table of Drugs
Topotecan and Doxorubicin Combination to Treat Recurrent
Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic
Identification of Cisplatin Sensitizers Through High-Throughput Combinatorial Screening
Hycamtin, INN-Topotecan
Full Prescribing Information for TOPOTECAN INJECTION
New Trends for Overcoming ABCG2/BCRP-Mediated Resistance
Emetogenic Potential of Antineoplastic Agents
HYCAMTIN 4 (Topotecan Hydrochloride) 5 for Injection 6 for INTRAVENOUS USE
A New Multidrug Reinduction Protocol with Topotecan, Vinorelbine